To further examine whether PD-L1 is a candidate chemoresistant marker for NSCLC samples, we compared the mRNA level of PD-L1 expression in the responder group (n = 17) with that in the nonresponder group (n = 12) of the cohort study. This evidence concerns the gene CD274 and non-small cell lung carcinoma.